Differentiation induction as a treatment for hematologic malignancies.
Miller
Wilson H
WH
Lady Davis Institute for Medical Research and SMBD Jewish General Hospital, McGill University, Montreal H3T1E2, Quebec, Canada.
Waxman
Samuel
S
D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000494:pharmacology; D002454:Cell Differentiation; D019337:Hematologic Neoplasms / Q000378:metabolism* / Q000628:therapy*; D015473:Leukemia, Promyelocytic, Acute / Q000378:metabolism / Q000628:therapy; D008954:Models, Biological; D015514:Oncogene Proteins, Fusion / Q000378:metabolism; D010087:Oxides / Q000494:pharmacology; D015398:Signal Transduction; D014158:Transcription, Genetic
D001152:Arsenicals; D015514:Oncogene Proteins, Fusion; D010087:Oxides; D000077237:Arsenic Trioxide